livzon pharma (01513) announced that on November 21, 2024, the company will spend 2.0951 million Hong Kong dollars to repurchase shares.
According to a report from Zhitong Finance APP, livzon pharma (01513) announced that on November 21, 2024, the company will spend 2.0951 million Hong Kong dollars to buy back 0.0786 million shares at a repurchase price of 26.50-26.75 Hong Kong dollars per share.
On November 21, 2024, the company will spend 4.7412 million yuan to repurchase 0.125 million A-shares at a repurchase price of 37.88-37.96 yuan per share.